Target intelligence / Profile preview

DNA nucleobases (DNA)

Target
DNA
Molecular classification
Nucleic acid
01

Overview

DNA nucleobases, comprising adenine, guanine, cytosine, and thymine, are the structural components of deoxyribonucleic acid (DNA) that encode the genetic instructions for all living organisms (National Human Genome Research Institute, 2024). Located within the cell nucleus, these bases are essential for the high-fidelity storage and transmission of genetic information during cell division and protein synthesis (Nature Education, 2014). In oncology, DNA nucleobases are classic therapeutic targets; drugs like alkylating agents and platinum complexes bind directly to these bases—most frequently guanine—to form adducts and cross-links (StatPearls, 2023). These structural alterations interfere with the unwinding of the DNA double helix, stalling replication forks and inhibiting transcription (NIH/NCI, 2023). This mechanism is particularly effective against rapidly proliferating cancer cells but also affects normal dividing cells, leading to characteristic toxicities and the risk of long-term genomic instability (American Cancer Society, 2024).

Other names
Genomic DNADeoxyribonucleic acidNitrogenous basesNuclear DNADNA bases
02

Mechanism of action

Drugs targeting DNA nucleobases typically act through covalent modification (alkylation), inter- or intra-strand cross-linking, or intercalation (PubChem, 2024). These actions physically obstruct the machinery required for DNA replication and RNA transcription, leading to DNA strand breaks and the activation of DNA damage response pathways, which ultimately induce programmed cell death (apoptosis) in susceptible cells (PubMed, 2022).

03

Biological functions

Genetic information storageDNA replicationTranscriptionCell division
04

Disease associations

CancerGenetic disordersViral infection
05

Safety considerations

MutagenicitySecondary malignancies (e.g., therapy-related leukemia)MyelosuppressionNephrotoxicityOtotoxicityTeratogenicityInfertility
06

Interacting drugs

Cisplatin

11 more in the full profile.

07

Biomarkers

O6-methylguanine-DNA methyltransferase (MGMT) promoter methylationMicrosatellite instability (MSI)Tumor mutational burden (TMB)DNA adduct levelsp53 mutation status

Beyond the preview

Go deeper on DNA nucleobases (DNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA nucleobases (DNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call